A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours
Status:
Completed
Trial end date:
2018-06-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore safety and efficacy of varlitinib administered as
monotherapy in Japanese subjects with advanced or metastatic solid tumors, and administered
as combination with capecitabine in Japanese subjects with advanced or metastatic biliary
tract cancer. Also to evaluate pharmacokinetics (PK) of varlitinib, capecitabine and its
metabolite.